Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rilonacept for Inflammation in CKD
NCT00897715Phase 2Completed
- Sponsor
- VA Office of Research & Development
- Start
- Jan 2013
- Primary completion
- Feb 2015
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of rilonacept in chronic kidney disease (CKD), sponsored by VA Office of Research & Development. Started Jan 2013; status: completed.
02
Drugs
rilonacept
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT00897715.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00897715.